IMJ February 2026 #FreeAccess
Brief Communication: Prolonged waiting times for respiratory and sleep care bit.ly/4rIKBV3
@theracp.bsky.social
IMJ February 2026 #FreeAccess
Brief Communication: Prolonged waiting times for respiratory and sleep care bit.ly/4rIKBV3
@theracp.bsky.social
@theracp.bsky.social
23.02.2026 01:01 β π 0 π 0 π¬ 0 π 0
IMJ February 2026 #FreeAccess
Original Article: Voluntary assisted dying and organ donation bit.ly/4rfPllq @theracp.bsky.social
IMJ February 2026 #FreeAccess
Clinical Perspectives: Giant cell arteritis: recent therapeutic advances bit.ly/3Ndhn1B
@theracp.bsky.social
IMJ February 2026 #FreeAccess
Editorial: Surveillance for poliovirus is just as important as ever bit.ly/4r8t3C1 @theracp.bsky.social @ianjohnwoolley.bsky.social
IMJ February 2026 #FreeAccess
Editor's Choice (Review): Midodrine in heart failure bit.ly/4aH5p9K
@theracp.bsky.social
IMJ February (Vol 56, Iss 2) is now online
bit.ly/4kqgD5L @theracp.bsky.social
@marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social
IMJ January 2026 #FreeAccess
Brief Communication: Hepatic steatosis incidentally detected on lung cancer screening bit.ly/3Z2qGUD
@theracp.bsky.social
IMJ January 2026 #OpenAccess
Brief Communication: Tertiary hospital-based gender affirming care bit.ly/4jtRiHE
@theracp.bsky.social
IMJ January 2026 #FreeAccess
Original Article: Cholesterol treatment in type 1 diabetes bit.ly/4jMp8HS
@theracp.bsky.social
IMJ January 2026 #FreeAccess
Original Article: Iron deficiency and anaemia in inflammatory bowel disease bit.ly/45DdAB1
@theracp.bsky.social
IMJ January 2026 #FreeAccess
Review: Management of HIV in cardiovascular disease bit.ly/3Z5qwfe
@theracp.bsky.social @ianjohnwoolley.bsky.social
IMJ January 2026 #FreeAccess
Editorial: I visited 145 Macquarie Street bit.ly/3Z3uYet
@theracp.bsky.social
IMJ January 2026 #FreeAccess
Editor's Choice (Review): Thiazide-induced hyponatraemia bit.ly/3Z3vk4R
@theracp.bsky.social
IMJ January (Vol 56, Iss 1) is now online
bit.ly/45NHpim
@theracp.bsky.social @marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social
IMJ December 2025 #FreeAccess
Brief communication: Top 10 research priorities in inflammatory bowel disease bit.ly/3YmODFU
@theracp.bsky.social
IMJ December 2025 #FreeAccess
Original Article: Outcomes in acute kidney injury bit.ly/4pqiucs
@theracp.bsky.social @sunilbadve.bsky.social
IMJ December 2025 #FreeAccess
Original Article: Convalescent plasma in hospitalised patients with COVID-19 bit.ly/4q5DMvX
@theracp.bsky.social
IMJ December 2025 #OpenAccess
Clinical Perspective: HIV: is it now a thing of the past? bit.ly/3KQ2AZX
@theracp.bsky.social
IMJ December 2025 #OpenAccess
Review: Systemic autoimmune rheumatic diseases bit.ly/3MnT0hv
@theracp.bsky.social
IMJ December 2025 #FreeAccess
Editorial: We Still Need to Think Critically About Positive Thinking in Healthcare bit.ly/4pxBSEE
@theracp.bsky.social
IMJ December 2025 #FreeAccess
Editor's Choice (Original Article): What do general medicine perioperative services do? bit.ly/4q5DIMJ
@theracp.bsky.social
IMJ December (Vol 55, Iss 12) is now online
bit.ly/4pWJiRu
@theracp.bsky.social
@marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social
IMJ November 2025 #FreeAccess
Original Article: Troponin rise in Fabry disease bit.ly/3JOWVCR
@theracp.bsky.social
IMJ November 2025 #FreeAccess
Original Article: Psychosocial wellbeing of adolescent and young adults with chronic illness bit.ly/4qM0KcK
@theracp.bsky.social
IMJ November 2025 #FreeAccess
Original Article: Hepatitis B in transplant recipients bit.ly/3LJRy8u
@theracp.bsky.social
IMJ November 2025 #OpenAccess
Clinical Perspective: Narcolepsy 2025 bit.ly/4nK4s3Z
Narcolepsy is a rare disorder of central hypersomnolence which significantly impacts affected individuals. This article reviews the current landscape of narcolepsy in Australasia.
@theracp.bsky.social
IMJ November 2025 #FreeAccess
Review: Immune checkpoint inhibitor therapy bit.ly/4nEQzUo
As survival rates for cancer improve, a new class of treatment complication, immune related adverse events (irAEs) has emerged.
@theracp.bsky.social
IMJ November 2025 #FreeAccess
Editorial: Measuring clinical activities and outcomes for Gen Med
bit.ly/3LrBxUI
@theracp.bsky.social
IMJ November 2025 #OpenAccess
Editor's Choice (Original Article): What does βcomplexβ mean for the general medicine team?
bit.ly/47IAvem
@theracp.bsky.social